Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.

Trivedi P, Hematti P.

Exp Hematol. 2008 Mar;36(3):350-9. doi: 10.1016/j.exphem.2007.10.007. Epub 2008 Jan 7.

2.

Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.

Fu X, Chen Y, Xie FN, Dong P, Liu WB, Cao Y, Zhang WJ, Xiao R.

Tissue Eng Part A. 2015 Feb;21(3-4):616-26. doi: 10.1089/ten.TEA.2013.0651. Epub 2015 Jan 8.

4.

Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.

Brown PT, Squire MW, Li WJ.

Cell Tissue Res. 2014 Oct;358(1):149-64. doi: 10.1007/s00441-014-1926-5. Epub 2014 Jun 14.

5.

Human embryonic stem cell-derived mesenchymal stromal cells.

Hematti P.

Transfusion. 2011 Nov;51 Suppl 4:138S-144S. doi: 10.1111/j.1537-2995.2011.03376.x.

6.

Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.

Oh W, Kim DS, Yang YS, Lee JK.

Cell Immunol. 2008 Feb;251(2):116-23. doi: 10.1016/j.cellimm.2008.04.003. Epub 2008 May 20.

PMID:
18495100
7.

[Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].

Li F, Lyu J, Duan Y, Sun Y, Li D, Wang Y, Hu X, Xiao D.

Zhonghua Xue Ye Xue Za Zhi. 2014 Oct;35(10):891-6. doi: 10.3760/cma.j.issn.0253-2727.2014.10.004. Chinese.

PMID:
25339324
8.

Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells.

Liu YP, Hematti P.

Cytotherapy. 2009;11(6):716-25. doi: 10.3109/14653240903051566.

9.

Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro.

Tan Z, Su ZY, Wu RR, Gu B, Liu YK, Zhao XL, Zhang M.

J Zhejiang Univ Sci B. 2011 Jan;12(1):18-27. doi: 10.1631/jzus.B1000074.

10.

Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S.

PLoS One. 2013;8(1):e55319. doi: 10.1371/journal.pone.0055319. Epub 2013 Jan 29.

11.

[IMMUNOGENICITY OF HUMAN UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELLS AFTER OSTEOGENIC INDUCTION].

Yang D, Lin H, Liu G.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Jun;28(6):752-7. Chinese.

PMID:
26455231
12.

Characterization of mesenchymal stem cells from human vocal fold fibroblasts.

Hanson SE, Kim J, Johnson BH, Bradley B, Breunig MJ, Hematti P, Thibeault SL.

Laryngoscope. 2010 Mar;120(3):546-51. doi: 10.1002/lary.20797.

13.

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells.

Bocelli-Tyndall C, Zajac P, Di Maggio N, Trella E, Benvenuto F, Iezzi G, Scherberich A, Barbero A, Schaeren S, Pistoia V, Spagnoli G, Vukcevic M, Martin I, Tyndall A.

Arthritis Rheum. 2010 Dec;62(12):3815-25. doi: 10.1002/art.27736.

14.

Immune properties of human umbilical cord Wharton's jelly-derived cells.

Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR.

Stem Cells. 2008 Nov;26(11):2865-74. doi: 10.1634/stemcells.2007-1028. Epub 2008 Aug 14.

15.

Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro.

Niemeyer P, Kornacker M, Mehlhorn A, Seckinger A, Vohrer J, Schmal H, Kasten P, Eckstein V, Südkamp NP, Krause U.

Tissue Eng. 2007 Jan;13(1):111-21.

PMID:
17518585
16.

Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.

Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y.

Int J Mol Med. 2014 Sep;34(3):695-704. doi: 10.3892/ijmm.2014.1821. Epub 2014 Jun 25.

17.

Human neonatal thymus-derived mesenchymal stromal cells: characterization, differentiation, and immunomodulatory properties.

Siepe M, Thomsen AR, Duerkopp N, Krause U, Förster K, Hezel P, Beyersdorf F, Schlensak C, Südkamp NP, Bosse R, Niemeyer P.

Tissue Eng Part A. 2009 Jul;15(7):1787-96. doi: 10.1089/ten.tea.2008.0356.

PMID:
19132892
18.

Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.

Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H.

Stem Cells Transl Med. 2013 Jun;2(6):455-63. doi: 10.5966/sctm.2012-0184. Epub 2013 May 21.

19.

Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.

Zhou C, Yang B, Tian Y, Jiao H, Zheng W, Wang J, Guan F.

Cell Immunol. 2011;272(1):33-8. doi: 10.1016/j.cellimm.2011.09.010. Epub 2011 Sep 29.

20.

Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.

Zhang Z, Han Y, Song J, Luo R, Jin X, Mu D, Su S, Ji X, Ren YF, Liu H.

J Oral Pathol Med. 2015 Jan;44(1):15-27. doi: 10.1111/jop.12224. Epub 2014 Sep 12.

PMID:
25212102
Items per page

Supplemental Content

Write to the Help Desk